(Q35057308)
Statements
1 reference
Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis (English)
1 reference
Karen R Sommers
1 reference
Michele C Azada
1 reference
Edward B Garon
1 reference
7 January 2015
1 reference
1 reference
20
1 reference
2
1 reference
224-226
1 reference
Identifiers
1 reference
1 reference
1 reference